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A B S T R A C T
Gliomatosis peritonei (GP) is a rare condition that occurs almost exclusively in the setting of ovarian immature teratoma. It 
is characterisized by the occurrence of nodules of mature glial tissues in the peritoneum, omentum and bowel wall. The glial 
tissue in such cases is usually low grade although there have been cases of malignant evolution described. In general, the 
prognosis for GP is good. It depends chiefly on the degree of maturity of the implants. In mature GP, usually no additional 
chemotherapy is necessary. In immature GP, chemotherapy can induce maturation of the implants. We present a case of 
immature ovarian teratoma associated with low grade GP.
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Case Report
INTRODUCTION
Immature teratoma is a preferred term for the malignant 
ovarian teratoma usually seen in children and adolescents 
and is composed of a mixture of embryonal and adult 
tissues derived from all three germ layers regardless of 
its gross appearance.[1] It spreads on pelvic, abdominal 
peritoneum and omentum.
In patients with extra ovarian spread, the microscopic 
appearance of the metastasis is of prognostic importance. 
Some peritoneal implants or lymph node metastasis 
contain only mature tissues and do not adversely affect 
the prognosis. These implants are usually composed partly 
or completely of mature glial tissue (gliomatosis peritonei 
(GP)).[2]
Despite often widespread involvement of peritoneal 
surface, GP is reported to impart an improved prognosis 
even in high grade teratomas. However, a long-term follow 
up even in the face of mature glial implants is highly 
recommended because of established cases of malignant 
transformation of glial components long after initial 
surgery.[3]
CASE REPORT
A 22-year-old female came to out-patient department 
of Obstetrics and Gynecology of NKPSIMS and Lata 
Mangeshkar Hospital, Nagpur, with a history of abdominal 
pain and increase in abdominal volume of 5-6 months 
duration. Her family history was unremarkable. Physical 
examination revealed a huge abdominpelvic mass. 
Ultrasound and CT scan revealed an abdominopelvic mass 
of 35 cm × 30 cm diameter arising from the left ovary 
without lymphadenopathy or liver metastasis.
Preoperative tumor markers were high with an alpha 
fetoprotein (AFP) levels of 3100 ng/ml and Ca 125 level of 
3600 U/ml.
Patients presented with this complaint to outpatient 
department (OPD) of NKPSIMS.
Laparotomy revealed huge left-sided ovarian mass. There 
was parametrial thickening on both the sides. Peritoneum, 
omentum and peritoneal surfaces were grossly normal. No 
nodules were seen.
Gross
Left ovarian mass weighed 8 kg and measured 
35 cm × 30 cm × 15 cm. The external surface was 
bosseleted [Figure 1] and a cut section showed multiple 
nodular solid areas and cystic spaces with mucoid 
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material [Figure 2]. Gritty areas were also present. Uterus, 
cervix, right ovary and fallopian tube were unremarkable. 
Parametrium was thickened on both the sides. A specimen 
of omentum was received measuring 30 × 10 cm. Grossly 
no nodules or deposits were visible.
Microscopy
Sections from the ovarian mass revealed a tumor composed 
of mixture of mature and immature elements from all the 
three germ layers. Mature adipose tissue, cartilage, stratified 
squamous epithelium and glandular spaces lined by columnar 
to flattened cells were seen [Figure 3]. Foci of fibrillary 
neural tissue, glial tissue, ganglion cells, melanin pigment, 
areas of calcification, skin and adnexal structure were also 
seen. Focal areas showed primitive mesenchyme. Immature 
neural tissue was seen in the form of primitive neural tubes 
and rosettes [Figure 4]. Areas suggesting yolk sac tumor 
or embryonal carcinoma were not seen. These histological 
features were suggestive of immature teratoma (Grade 1). 
Sections form parametrium showed mature teratoma 
elements. Foci of adipose tissue, cartilage and glandular 
spaces were seen. Sections from omentum revealed many 
foci of mature glial tissue (Grade 0) [Figure 5]. There was 
no nuclear atypia or mitoses.
A diagnosis of immature teratoma (Grade 1) with multiple 
glial implants in omentum (Grade 0) was made.
DISCUSSION
Immature teratoma is a preferred term for the malignant 
ovarian teratoma usually seen in first and second decade 
of life. It is composed of mixture of embryonal and adult 
tissues derived from all three germ layers regardless of its 
gross appearance.[1] Immature teratoma represents 3% of 
all teratoma, 1% of all ovarian cancer and 20% of malignant 
ovarian germ cell tumors. In grading of immature teratoma, 
primitive neural tubes and immature rosettes are counted.[4]
Immature teratoma is a predominantly solid, unilateral 
tumor that averages 18 cm in diameter. The Solid 
component is gray or brown and soft to hard in 
consistency. Scattered small cysts are typically seen on the 
cut surface.[2] If keratinous debris or hairs are seen it may 
resemble a dermoid cyst.
Components of all the three germ layers are present and a 
mixture of mature or immature elements with haphazard 
distribution can be seen. The immature elements are 
mainly mesenchymal and ectodermal in origin. Immature 
neuroectodermal tissue is the easiest immature tissue to 
recognize and quantitate. Patients may sometimes present 
with paraneoplastic syndrome like limbic encephalitis.[4]
In patients with extra ovarian spread, the microscopic 
appearance of the metastasis is of prognostic importance. 
Some peritoneal implants or lymph node metastases 
contain only mature tissues and do not adversely affect the 
prognosis. These grade 0 implants are usually composed 
partly or completely of mature glial tissue. GP is a rare 
occurrence and has been found exclusively in females with 
ovarian teratoma (immature and rarely in mature), though 
there are stray reports of its association with pregnancy and 
ventriculoperitonial shunts performed for hydrocephalus.[3,5] 
The first case of immature teratoma with GP from India was 
reported by Joshi et al. in 1981.[3] A review of the literature 
reported by Chou et al. had found 65 cases of GP, which 
have favorable prognosis after surgical treatment.[6]
The mechanism of implantation is unknown and two 
theories to explain the origin of GP have been proposed. 
In one glial implant arise from the teratoma and in 
Figure 1: Gross photograph showing a tumor (mass) with multinodular 
appearance on external surface
Figure 2: Gross photograph of the cut surface of the tumor showing 
multiple nodular and cystic areas
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the other, pluripotent stem cells in the peritoneum or 
adjacent mesenchyme undergo glial metaplasia.[6] Recent 
molecular studies of glial implants have shown that they 
are genetically different from an ovarian tumor but have 
same genetic patterns as patient.[2] Substances produced by 
a tumor result in metaplastic transformation of peritoneal 
or subperitoneal tissue into glial tissue.[2]
Patients with recurrent teratoma may be affected with the 
tumor-prone syndrome, where one or more peritoneal 
cell types or population are predisposed to neoplastic 
conversion and formation of tumors as a result of an 
endogenous or exogenous neoplastic stimuli.[7]
Glial fibrillary acidic protein (GFAP) is an intermediate 
filament protein that expresses with the development of 
astrocytes in the fetal nerve tissue. GFAP immunostain 
confirms the glial nature of the tissue. A strong expression 
of GFAP often suggests that tumor cells are mature and well 
differentiated.[8]
Surgery and multi-dose chemotherapy is the main line 
of treatment. In general, the prognosis of GP is good. It 
depends chiefly on the degree of maturity of the implants. In 
mature GP, usually no additional chemotherapy is necessary. 
In immature GP chemotherapy can induce maturation of the 
implants.[9]
The growing teratoma syndrome (GTS) is defined as conversion 
of a metastatic immature teratoma into a metastatic mature 
teratoma as a result of chemotherapy. GTS rarely occurs in 
association with ovarian germ cell tumors.[10] The prognosis 
of this benign entity however remains favorable, with the 
survival of up to 9 years in completely resected cases.
Recurrence is influenced by several factors, such as tumor 
grade, growth pattern, capsular rupture and vascular 
invasion.[8] It is also important to separate immature 
teratomas that have a yolk sac or embryonal tumor pattern, 
since the prognosis substantially decreases under these 
circumstances.[8]
The risk of metastasis correlates with the amount of 
immature neuroepithelial tissue present and this is taken 
into account for grading according to the system of Robbry 
and Scully modified by Norris et al.[10]
When associated with mature glial implants within 
the peritoneum the prognosis is usually much better, 
Irrespective of the original tumor grade.[10] There have 
been rare descriptions of cases of mature GP which have 
evolved into malignant tumors long after initial surgery. 
Hence, long-term follow up even in the face of mature glial 
implants is highly recommended.
On follow up our patient was found to be disease free 
2 years after the surgery.
Figure 3: Photomicrograph showing mature elements cartilage, glandular 
epithelium (H and E, ×100)
Figure 4: Photomicrograph showing immature neural tissue (H and E, ×100)
Figure 5: Photomicrograph showing glial implants in peritoneum 
(H and E, ×100)
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